rs56689668

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_000054.7(AVPR2):​c.26-6T>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 1.0 ( 38892 hom., 33978 hem., cov: 24)
Exomes 𝑓: 1.0 ( 360821 hom. 349485 hem. )
Failed GnomAD Quality Control

Consequence

AVPR2
NM_000054.7 splice_region, intron

Scores

2
Splicing: ADA: 0.01070
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.0360

Publications

12 publications found
Variant links:
Genes affected
AVPR2 (HGNC:897): (arginine vasopressin receptor 2) This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
AVPR2 Gene-Disease associations (from GenCC):
  • diabetes insipidus, nephrogenic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nephrogenic syndrome of inappropriate antidiuresis
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • nephrogenic diabetes insipidus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-153905526-T-G is Benign according to our data. Variant chrX-153905526-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 254772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000054.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AVPR2
NM_000054.7
MANE Select
c.26-6T>G
splice_region intron
N/ANP_000045.1P30518-1
AVPR2
NM_001146151.3
c.26-6T>G
splice_region intron
N/ANP_001139623.1P30518-2
AVPR2
NR_027419.2
n.465+356T>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AVPR2
ENST00000646375.2
MANE Select
c.26-6T>G
splice_region intron
N/AENSP00000496396.1P30518-1
AVPR2
ENST00000337474.5
TSL:1
c.26-6T>G
splice_region intron
N/AENSP00000338072.5P30518-1
AVPR2
ENST00000370049.1
TSL:1
c.26-6T>G
splice_region intron
N/AENSP00000359066.1P30518-2

Frequencies

GnomAD3 genomes
AF:
1.00
AC:
111732
AN:
111762
Hom.:
38897
Cov.:
24
show subpopulations
Gnomad AFR
AF:
1.00
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
1.00
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
0.992
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
1.00
GnomAD2 exomes
AF:
0.999
AC:
130924
AN:
131006
AF XY:
0.999
show subpopulations
Gnomad AFR exome
AF:
1.00
Gnomad AMR exome
AF:
1.00
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
0.992
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
1.00
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
1.00
AC:
1071431
AN:
1071907
Hom.:
360821
Cov.:
43
AF XY:
1.00
AC XY:
349485
AN XY:
349645
show subpopulations
African (AFR)
AF:
1.00
AC:
25628
AN:
25628
American (AMR)
AF:
1.00
AC:
31626
AN:
31626
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
18900
AN:
18900
East Asian (EAS)
AF:
0.984
AC:
28065
AN:
28521
South Asian (SAS)
AF:
1.00
AC:
51515
AN:
51521
European-Finnish (FIN)
AF:
1.00
AC:
37803
AN:
37803
Middle Eastern (MID)
AF:
1.00
AC:
3386
AN:
3387
European-Non Finnish (NFE)
AF:
1.00
AC:
829515
AN:
829517
Other (OTH)
AF:
1.00
AC:
44993
AN:
45004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21408
42816
64224
85632
107040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
1.00
AC:
111784
AN:
111814
Hom.:
38892
Cov.:
24
AF XY:
1.00
AC XY:
33978
AN XY:
33984
show subpopulations
African (AFR)
AF:
1.00
AC:
30815
AN:
30815
American (AMR)
AF:
1.00
AC:
10718
AN:
10719
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
2658
AN:
2658
East Asian (EAS)
AF:
0.992
AC:
3486
AN:
3514
South Asian (SAS)
AF:
1.00
AC:
2681
AN:
2682
European-Finnish (FIN)
AF:
1.00
AC:
6068
AN:
6068
Middle Eastern (MID)
AF:
1.00
AC:
219
AN:
219
European-Non Finnish (NFE)
AF:
1.00
AC:
52935
AN:
52935
Other (OTH)
AF:
1.00
AC:
1527
AN:
1527
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
1.00
Hom.:
12656
Bravo
AF:
1.00

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
4
not provided (4)
-
-
2
Diabetes insipidus, nephrogenic, X-linked (2)
-
-
1
Nephrogenic syndrome of inappropriate antidiuresis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
11
DANN
Benign
0.59
PhyloP100
-0.036
PromoterAI
-0.0028
Neutral
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.011
dbscSNV1_RF
Benign
0.16
SpliceAI score (max)
0.21
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.21
Position offset: -18

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56689668; hg19: chrX-153170980; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.